Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of AG-014699 in BRCA1/2-mutated advanced breast or ovarian cancer
2006-002348-27Phase 2Terminated
- Sponsor
- Cancer Research UK
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of rucaparib in breast cancer and ovarian cancer (2 arms), sponsored by Cancer Research UK. Primary endpoint: Antitumor activity. Started Jul 2007; status: terminated.
02
Drugs
rucaparib
03
Conditions
breast cancerovarian cancer
Beyond the preview
Go deeper on 2006-002348-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002348-27.